CRO Achieves Rapid Response, Increased Acceptance Rate Via Data-Driven Clinical Trial Site ID and Outreach Approach

Clinical trial site identification (ID) and outreach are often inefficient due to manual, paper-based processes, placing a heavy burden on both contract research organizations (CROs) and the clinical study sites with which they work.

A top five global CRO wanted to supplement their current site ID and outreach processes, expand and nurture healthcare organization (HCO) relationships, and broaden their existing potential site list—all with the goal of running clinical trials more efficiently and cost effectively for their customers.